arrow
C

Christoph Wyen

faculty of medicine
H指数:33
被引数:4,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis

2019-2020年德国艾滋病晚期诊断特征——一项区域分析

2026-08-250
OAAI
Both Smallpox and Mpox Vaccine Reduce Mpox Disease Severity and Symptoms

天花和猴痘疫苗均可减轻猴痘疾病的严重程度和症状

2026-04-150
OA
Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany

德国人类免疫缺陷病毒与乙型肝炎病毒合并感染者中丁型肝炎病毒的感染流行率

2025-11-070
OAAI
The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort study

抗生素治疗对中度COVID-19住院患者临床结局的影响:一项前瞻性多中心队列研究

2025-06-260
OAAI
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study

MVA-BN疫苗接种在德国高风险个体中针对猴痘病毒的安全性及有效性(SEMVAc和TEMVAc):一项结合前瞻性和回顾性的队列研究

2025-03-180
OAAI
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America
2024-06-170
OAAI
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
2024-03-0124
OAAI
Dynamics and durability of HIV-1 neutralization are determined by viral replication
2023-11-132
OAAI
COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity
2022-10-124
OAAI
Monkeypox in Germany
2022-08-2226
OA
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C

宿主KIR/hla-c基因型决定了HIV介导的NK细胞库的变化,并与影响hla-c下调的Vpu序列变异有关。

2022-07-158
OAAI
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial
2022-01-2589
OAAI
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

在接受达沙替尼和抗逆转录病毒治疗的HIV-1感染者中,前病毒再激活受到损害

2021-10-0114
OAAI
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
2020-08-1319
OAAI
Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies
2020-03-1217
OAAI